MEMOTEXT, a company specializing in developing and delivering personalized digital health interventions, today announced a collaboration with Massachusetts General Hospital (MGH) to create a text-messaging-based program that can help address the issue of medication adherence in children with attention deficit /hyperactivity disorder (ADHD). The collaboration aims to advance and make available to patients and families
READ MORE
There is much talk about the need to embrace digital health solutions as one of the key strategies needed to successfully compete in a transformed value-driven healthcare delivery environment but what are the detailed mechanisms by which we can facilitate this change. In this working-group we want to define the success metrics in greater detail
READ MORE
Optimal Birth BC, a partnership between academic researchers from UBC and provincial health authorities, have launched a research program to examine the effectiveness and scalability of a prenatal education program delivered by text messaging for expectant women in BC. The study will include all pregnant women with a specific focus on increasing accessibility to women
READ MORE
Allergan Inc. has partnered with STI Technologies Limited and MEMOTEXT to launch the Restasis® treatment support pilot program: a digital health patient adherence and support program aimed at improving medication adherence for patients with dry eye. The pilot program was first launched in the province of Ontario and has recently been expanded to include the
READ MORE
I’ve now recovered from my #MedXhangover. The term commonly used to refer to the general malaise that the majority of attendees experience once they return to real-life after spending three days living within the confines of Stanford MedicineX (MedX) community. MedX is not your average run-of-the-mill healthcare conference. MedX is different. It tries and succeeds
READ MORE
The HIV Prevention Trials Network (HPTN) has launched a research study examining the feasibility and scalability of an integrated, enhanced, case manager care strategy to attain and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States. The study is being conducted in four US cities with 356 participants
READ MORE
MEMOTEXT is returning to Stanford MedX! On Sunday September 18 @ 11:00AM come and visit us in the lower lobby. We will be presenting our poster entitled: Using personalized digital health behavior change to manage asthma.Check out our abstract below and hopefully we’ll see you there! If you can’t make it, let us know. We’ll
READ MORE
CAMH and MEMOTEXT sign MOU to co-develop mobile health intervention for schizophrenia (TORONTO) May 11, 2016 – The Centre for Addiction and Mental Health (CAMH) and MEMOTEXT Corporation have signed a memorandum of understanding (MOU) to develop and commercialize an award-winning mobile health intervention for people with schizophrenia. The app will engage patients more fully
READ MORE
Today, we presented an update to our Balanced Adherence Metric at the PQA Annual Meeting & Innovation Forum in Arlington, VA. Objectively evaluating adherence is difficult. Beyond checking blood levels of the medication in question, assessments are limited to proxy measures. These measures have varying degrees of error and reliability. Due to its relative availability,
READ MORE
The Balanced Adherence Metric (BAM): a new spin on current methods for calculating adherence with pharmacy claims data. Bill Simpson, B.Sc, Ph.D (1,2) and Amos Adler, M.Sc. (2) McMaster University, Hamilton, Ontario, Canada MEMOTEXT Corporation, Toronto, Ontario, Canada Purpose/Objective: While Proportion of Days Covered (PDC) quantifies adherence (from claims data) in patients
READ MORE
